Eli Lilly reported third-quarter results before the market opened on Wednesday. Management missed Wall Street estimates and lowered earnings guidance for 2024. Sales of Zepbound and Mounjaro ...

Some investors could be tempted to sell. I think that's a temptation to avoid. Here's why Eli Lilly is a no-brainer stock to buy on the dip. Concerns about Lilly's Q3 update are overblown It's not ...

Republican Rep. Eli Crane won reelection to a U.S. House seat representing Arizona on Saturday. Crane, a freshman lawmaker, defeated former Navajo Nation President Jonathan Nez, who was vying to ...

Eli Lilly has seen massive returns this year and is one of the most expensive healthcare stocks in the world. Its new products have strong growth prospects, but their potential may still be ...

Paulo Nunes dos Santos / Bloomberg via Getty Images Eli Lilly will report third-quarter earnings Wednesday morning, with the focus remaining on the production and sales of its popular weight-loss ...

A change in the dosing regimen of Eli Lilly’s Alzheimer’s drug Kisunla resulted in a lower rate of brain swelling among patients in a clinical trial, new data reported Tuesday show.

Eli Lilly is expanding its innovation digs to Beijing, opening two research centers called the Eli Lilly China Medical Innovation Center and Lilly Gateway Labs. The newest Gateway Lab is the ...

Yet, Eli Lilly's GLP-1 medications are helping it compete with the leader. Plus, Lilly also has several other promising catalysts to consider. These are two of healthcare's biggest darlings right ...

Shares of Eli Lilly have gained considerably throughout 2024, thanks in large part to the company's success in diabetes and obesity care. Outside of weight loss, Eli Lilly has a major opportunity ...

NEW YORK (AP) — U.S. stock indexes edged lower Wednesday after drops for Eli Lilly and chip companies overshadowed a jump for Google's parent company. The S&P 500 slipped 0.3% after drifting ...

Veteran corner back Eli Apple is set to be signed by the Los Angeles Chargers, according to NFL Network's Tom Pelissero. Tom Pelissero @TomPelissero The <a href ...

Eli Lilly recently announced plans to build a new facility focused on clinical research and manufacturing. This follows the company's acquisition of a manufacturing facility earlier this year ...